The basal subtype, with high expression of basal KRTs, has a worse prognosis and a greater similarity to basal-like subtypes in breast cancer, while the luminal subtype has a better prognosis and is associated with FGFR3 mutations. This evidence concerns the gene FGFR3 and breast carcinoma.